ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

California’s $3-billion bet on stem cells faces final test – Nature.com

Continue reading

2017-04-26 Michael Zand NEWS

California’s $3-billion bet on stem cells faces final test – Nature.com


Nature.com

California’s $3-billion bet on stem cells faces final test
Nature.com
When California voters approved US$3 billion in funding for stem–cell research in 2004, biologists flocked to the state, and citizens dreamed of cures for Parkinson’s disease and spinal-cord injuries. Now, the pot of money — one of the biggest state …
Ethics should partner with science in research and developmentIdaho Mountain Express and Guide
Aspen Institute now offering regenerative STEM Cell therapyMilTech

all 2 news articles »

Continue reading

2017-04-26 Michael Zand NEWS

Product News: UMMS Researchers Receive amfAR Grant to Eliminate HIV Reservoirs Using Gene Editing – SelectScience


Nature.com

California’s $3-billion bet on stem cells faces final test
Nature.com
When California voters approved US$3 billion in funding for stem–cell research in 2004, biologists flocked to the state, and citizens dreamed of cures for Parkinson’s disease and spinal-cord injuries. Now, the pot of money — one of the biggest state …
Ethics should partner with science in research and developmentIdaho Mountain Express and Guide
Aspen Institute now offering regenerative STEM Cell therapysatPRnews (press release)

all 2 news articles »

Continue reading

2017-04-26 Michael Zand NEWS

BRIEF-Intellia Therapeutics, Crispr Therapeutics announce US patent covering crispr/cas9 ribonucleoprotein complexes – Reuters

BRIEF-Intellia Therapeutics, Crispr Therapeutics announce US patent covering crispr/cas9 ribonucleoprotein complexesReutersBRIEF-Intellia Therapeutics, Crispr Therapeutics announce U.S. patent covering crispr/cas9 ribonucleoprotein complexes. April 26 … Continue reading

2017-04-26 Michael Zand NEWS

High-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying Kids – TheStreet.com

TheStreet.comHigh-Stakes Meeting Between Avexis and FDA Will Set the Course for Gene Therapy and Dying KidsTheStreet.comA small drug company flies to Washington, DC for a high-stakes meeting with FDA officials. If the meeting goes well, the company sec… Continue reading

2017-04-26 Michael Zand NEWS

Intellia (NTLA), CRISPR Therapeutics (CRSP) Receive U.S. Patent for CRISPR/Cas9 Ribonucleoprotein Complexes – StreetInsider.com

Markets DailyIntellia (NTLA), CRISPR Therapeutics (CRSP) Receive U.S. Patent for CRISPR/Cas9 Ribonucleoprotein ComplexesStreetInsider.comIntellia Therapeutics, Inc. (NASDAQ: NTLA) and CRISPR Therapeutics AG (NASDAQ: CRSP), two leading genome editing co… Continue reading

2017-04-26 Michael Zand NEWS

Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein … – GlobeNewswire (press release)

Intellia Therapeutics and CRISPR Therapeutics Announce U.S. Patent Covering CRISPR/Cas9 Ribonucleoprotein …GlobeNewswire (press release)CAMBRIDGE, Mass. and BASEL, Switzerland, April 26, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (… Continue reading

2017-04-26 Michael Zand NEWS

Study provides new insights on molecular mechanisms that impair muscle stem cells during aging – News-Medical.net

Study provides new insights on molecular mechanisms that impair muscle stem cells during agingNews-Medical.netResearchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a previously unrecognized step in stem cell-mediated m… Continue reading

2017-04-26 Michael Zand NEWS
  • 1
  • …
  • 1,798
  • 1,799
  • 1,800
  • 1,801
  • 1,802
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

SelectScience

Product News: UMMS Researchers Receive amfAR Grant to Eliminate HIV Reservoirs Using Gene Editing
SelectScience
But it turns out there’s a chance that another enzyme, Cpf1, could be a better fit for CRISPR when targeting HIV because of how HIV mutates upon replication. Luban and Wolfe theorize that since CRISPR/Cpf1 can target multiple sites on the genome, it …